Biologics

Regenexx® Releases Patient Outcomes Application for Orthopedic Stem Cell Treatments

BROOMFIELD, Colo., Dec. 13, 2016 /PRNewswire/ — Regenexx, a Colorado-based stem-cell-treatment network and pioneer in the invention of orthopedic stem cell injections, launched a new patient outcomes application to its website today. One of the many Regenexx differences is that it is transparent about its stem-cell-treatment results. With this new app, which is only available on the Regenexx website, you can easily see the results of what all participating Regenexx patients, not just a selected few, report regarding their outcomes following treatment.

The patient outcomes app allows you to search outcomes by body part, including ankle/foot, hand/wrist/elbow, hip, knee, shoulder, and spine. From there, you can select from a variety of outcome averages (“metrics”). For example, if you are looking at the knee arthritis, you can select specific outcomes to review, including percent improvement, average pain, average function scores (LEFS), and an additional function and pain score called the IKDC. For each body part, the app provides the number of patients who have reported outcomes, age ranges and average, BMI ranges and average, and numbers and percentages of male and female patients reporting. Each metric reviewed also includes a line graph showing reporting time points in months. Additionally, an explanation of the outcome data is provided below each graph.

Regenexx tracks almost ten thousand stem cell treated patients and actively collects outcome data via the Interventional Orthopedics Foundation Registry, the world’s largest and oldest stem-cell-treatment registry. Chris Centeno, MD, an International Expert in regenerative medicine and interventional orthopedics and founder of Regenexx, said, “No other clinic system on earth has the ability to show its patients their real time outcome data.” Dr. Centeno goes on to say, “While registry data always suffers from patients who fail to respond, the large numbers of patients being tracked allows for segmenting data in ways that smaller randomized controlled trials can’t.” This registry data is the tool Regenexx uses to provide actual patient outcomes on performance, pain, and function to anyone who wishes to read the data results.

While Regenexx has always provided outcomes reports on its website, this new app is another step forward in providing transparency on its stem cell treatments and procedures and in giving patients and potential patients a user-friendly avenue to research those outcomes.

The patient outcomes app can be accessed at http://www.regenexx.com/outcomes/.

Media Contact
Mark A. Testa
137545@email4pr.com
(303) 885-9630

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regenexx-releases-patient-outcomes-application-for-orthopedic-stem-cell-treatments-300377089.html

 

Tags

Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button